Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06347276
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-03-29
Brief Title:
Cerebral Microembolization Associated With PFO Closure
Sponsor:
China National Center for Cardiovascular Diseases
Organization:
China National Center for Cardiovascular Diseases
Study Overview
Official Title:
De Novo Cerebral Microembolization Associated With Patent Foramen Ovale Closure
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate 1 the de novo cerebral microembolization in patients who undergo transcatheter closure of PFO or ASD and 2 evaluate the relationship between de novo cerebral microembolization and in situ thrombus within PFO
Detailed Description:
Patent foramen ovale PFO is prevalent in the general population and it is commonly accepted that PFO is associated with various pathological conditions including ischemic stroke transient ischemic attack migraines and systemic or coronary embolization In situ thrombus formation may play a role in patients with PFO-associated stroke or migraines After transcatheter closure of PFO peri-interventional cerebral embolic lesions have been detected This study aims to investigate 1 the de novo cerebral microembolization in patients who undergo transcatheter closure of PFO or ASD and 2 evaluate the relationship between de novo cerebral microembolization and in situ thrombus within PFO
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None